Sign in
SCHEDULE 13G

Statement of Beneficial Ownership

Oruka Therapeutics, Inc. Filed Acc 0001897612-26-000718

Stakes reported in this filing

Reporting person Shares Of the class
T. Rowe Price Investment Management, Inc. 4,392,166 6.6%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…